Back

What is the impact on clinical practice of low-risk TAVI trials?

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Impact of low-surgical-risk TAVI trials on clinical decision making Diseases of the Aorta, Other ESC Premium Access ESC Congress 2019

About the speaker

Photo
Associate Professor Giuseppe Tarantini

University of Padua, Padova (Italy)

5 More presentations in this session

Presentation thumbnail
Welcome and introductions
Professor L. Pierard (Liege, BE)
Presentation thumbnail
Asymptomatic patients at risk with severe aortic stenosis
Professor L. Pierard (Liege, BE)
Presentation thumbnail
Clinical case - A low surgical risk patient undergoing TAVI
Professor T. Modine (Bordeaux, FR)
Presentation thumbnail
Do valve hemodynamic function and durability matter?
Professor P. Pibarot (Quebec, CA)
Presentation thumbnail
Questions and answers and panel discussion
Professor L. Pierard (Liege, BE)

Access the full session

Session thumbnail
Impact of low-surgical-risk TAVI trials on clinical decision making

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources